Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options. - sprookjes - yvandenbroek - TriplyDB

Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options.

Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options.

http://www.wikidata.org/entity/Q33460707

about

Coagulase-negative staphylococci.Susceptibility of bacterial etiological agents to commonly-used antimicrobial agents in children with sepsis at the Tamale Teaching Hospital.Comparative study using phenotypic, genotypic, and proteomics methods for identification of coagulase-negative staphylococci Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus.In vitro susceptibility to methicillin, vancomycin and linezolid of staphylococci isolated from bloodstream infections in eastern Turkey Intravenous device associated blood stream staphylococcal infection in paediatric patients Epidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentration.Prevalence of multidrug resistant Gram-positive cocci in a Chinese hospital over an 8-year period Glycopeptide resistance in gram-positive cocci: a review.Genetic analysis of glycopeptide-resistant Staphylococcus epidermidis strains from bone and joint infections.Current pattern of antibiotic resistance of clinical isolates among conjunctival swabs.Characterization of biofilm formation, antimicrobial resistance, and staphylococcal cassette chromosome mec analysis of methicillin resistant Staphylococcus hominis from blood cultures of children.Antibiotic resistance and biofilm formation among coagulase-negative staphylococci isolated from clinical samples at a tertiary care hospital of eastern Nepal.Clinical significance of coagulase-negative staphylococci isolates from nosocomial bloodstream infections.Staphylococcal Blood Stream Infections in Cancer Patients.Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt.Trend of vancomycin susceptibility of staphylococci at a level 1 trauma centre of India.[Oxacillin-resistant coagulase-negative Staphylococci bacteremia at a teaching hospital in Santa Maria, State of Rio Grande do Sul, Brazil].A proposal to unify two subspecies of Staphylococcus equorum: Staphylococcus equorum subsp. equorum and Staphylococcus equorum subsp. linens.Significance of methicillin-teicoplanin resistant Staphylococcus haemolyticus in bloodstream infections in patients of the Semmelweis University hospitals in Hungary.Central venous access in oncology: ESMO Clinical Practice Guidelines.Distribution of staphylococcal cassette chromosome mec types among methicillin-resistant coagulase negative staphylococci in central Iran.Temporal trends and predictors of antimicrobial resistance among Staphylococcus spp. isolated from canine specimens submitted to a diagnostic laboratory

P2860

Q30401758-72B14EC4-2EE4-4D11-B0AF-DF09DDCF78BA Q31111265-C232C044-38AB-425E-B61F-E547D5580466 Q34124898-4DE612A0-20A5-4588-9746-E26E54F54D1E Q34181643-DE5D321C-86F7-4FE8-8218-1AF82E7C30DA Q34380095-DA3281B7-5D04-4233-BD23-3FE024D35F4F Q35234581-F1FBA597-5F25-4D0C-B3AF-657D854916B8 Q35593072-395D43FA-77F0-4F9B-9B56-AB500CD11330 Q35958943-2FD26065-ABD1-422D-BBD4-EA771B94F552 Q36072225-942E3CB7-2C43-40CB-8159-45FF9513E784 Q36667520-9D1BA0D9-684E-49CD-ADB4-41261C53F7C5 Q37257789-54AC6415-E8A3-4B5F-9ECE-27E8401A313C Q38658706-C225FC26-57EF-4403-BC10-F9C52984F256 Q40061405-22336326-C5DD-4FC3-91DD-B050C8409D2D Q40872116-D3E7D10F-BACA-4C2E-BB0B-F9F31D7E096D Q41147051-85EE8056-6CCB-4900-9CA0-86163C7F6303 Q41711192-3241A4CE-5753-4097-841B-79E67127D639 Q42369114-025F9D29-C544-4B91-89D1-7FD52913CC63 Q42772513-A8A74307-6F18-463C-AE69-817CDE355773 Q48037635-3C33943A-9FA1-401E-AEC8-7DE64C4A5ADE Q51733600-0960AB05-5EB9-425B-8DEC-4B8963B5FD5B Q51792973-EC064AD2-9C6F-46D3-ADFB-1A53F59AFBAD Q55259924-7982285F-4B32-44B1-8197-763856B767CE Q57173470-75B3BCE3-3974-422A-B06E-682156C3E104

P2860

Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options.

http://www.wikidata.org/entity/Q33460707

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Characterization of coagulase- ...... tides and therapeutic options.

@ast

Characterization of coagulase- ...... tides and therapeutic options.

@en

type

label

Characterization of coagulase- ...... tides and therapeutic options.

@ast

Characterization of coagulase- ...... tides and therapeutic options.

@en

prefLabel

Characterization of coagulase- ...... tides and therapeutic options.

@ast

Characterization of coagulase- ...... tides and therapeutic options.

@en

P1433

Q33460707-3854E7BC-E414-4FC2-8641-8C0ACC19AB3A

P1476

Q33460707-58051B0C-8048-4732-AF8F-5968292293C3

P2093

Q33460707-05C1AF4C-BD8E-4593-B361-15BD163F6C0E

Q33460707-05E3328B-14CC-4CA3-BA25-D0B23156107A

Q33460707-5AD7F25D-554F-4F86-B907-9452D5E67287

Q33460707-6512CD08-76C1-47FE-BCFD-6DE42FBC9215

Q33460707-7DE31F8F-C59A-447C-811A-BA900EFA2BD5

Q33460707-82D8CFB1-914D-44DF-842E-C4B89D071103

Q33460707-8BC21324-18F0-4C70-9BF2-E838C2CD788A

Q33460707-A2552F35-AC00-44CC-BBE6-FEE97CAB660C

Q33460707-BBF917EB-8523-4085-BA8E-3E53BCE86FD6

Q33460707-C40CC05F-90A6-4A05-BAA4-EA8B1AEF92AA

P2860

Q33460707-1EB75296-79BC-489B-A851-BAA449A2FF18

Q33460707-32C5C869-8300-41F0-B65B-0D5CA54C037D

Q33460707-4BF719D1-CDEB-45CF-A93A-1DBAAC168CF5

Q33460707-5793B877-731B-4561-B192-390D99220167

Q33460707-6E693861-A815-40EC-8CDB-310223E55BF2

Q33460707-799681DC-D3AD-445B-9F98-8FABA61EE3BD

Q33460707-7F3B3811-2D56-4811-9A8C-9CA54E90D472

Q33460707-8EE6640D-471A-4E7D-B2A5-9457A90CB949

Q33460707-931985D9-D2FE-4DB8-9742-91DE25B034C2

Q33460707-980091A6-6678-4639-AD65-821781A1E846

P2888

Q33460707-CD25DE52-5911-48F6-8475-52318C430016

P304

Q33460707-F2DA029A-B31F-4BAE-80F8-46304142F058

P31

Q33460707-F205869E-1A14-4F69-AD7E-119FE8079EFE

P356

Q33460707-867611BD-770E-41C6-A98A-891892E6A8B0

P478

Q33460707-3CBBECC4-EEE9-4E3F-ACBC-234F33C4DFDC

P50

Q33460707-AD88B4E4-2740-404E-A85D-537A9C6BF755

P577

Q33460707-C9668F0C-5D63-4D4B-A896-38B6A4CD1C29

P5875

Q33460707-BC1F7868-69CB-4D60-9DBF-B62730EC5383

P6179

Q33460707-4710029F-EE40-4136-8990-A9F3851003DC

P698

Q33460707-BECFC9E3-5ABB-4561-91B8-521B84F95ECA

P932

Q33460707-4C4EB40A-C801-4FFC-8FA1-930B23F1D891

P356

P1433

BMC Infectious Diseases

P1476

Characterization of coagulase- ...... tides and therapeutic options.

@en

P2093

Alberto Bergamini

http://www.w3.org/2001/XMLSchema#string

Angela Beltrame

http://www.w3.org/2001/XMLSchema#string

Carla Fontana

http://www.w3.org/2001/XMLSchema#string

Francesca Leonardis

http://www.w3.org/2001/XMLSchema#string

Gian Piero Testore

http://www.w3.org/2001/XMLSchema#string

Giorgia Broglio

http://www.w3.org/2001/XMLSchema#string

Marco Favaro

http://www.w3.org/2001/XMLSchema#string

Maria Cristina Bossa

http://www.w3.org/2001/XMLSchema#string

Mauro Casapulla

http://www.w3.org/2001/XMLSchema#string

Raffaella Cerretti

http://www.w3.org/2001/XMLSchema#string

P2860

Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital

Comparative and library epidemiological typing systems: outbreak investigations versus surveillance systems.

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.

Vancomycin resistance in staphylococci.

Glycopeptide resistance in coagulase-negative staphylococci.

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

An overview of nosocomial infections, including the role of the microbiology laboratory.

Glycopeptide susceptibility profiles of nosocomial multiresistant Staphylococcus haemolyticus isolates.

Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides.

P2888

P304

83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-9-83

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26267348

http://www.w3.org/2001/XMLSchema#string

P6179

1044705183

http://www.w3.org/2001/XMLSchema#string

P698

19497104

http://www.w3.org/2001/XMLSchema#string

P932

2701436

http://www.w3.org/2001/XMLSchema#string